Join AmCham Shanghai's Healthcare Committee on March 7th from 9:30 to 11:00 AM on the 2019 Healthcare Industry Outlook at the AmCham Shanghai Conference Center.

In this session, we will hear from Fangning Zhang, Co-Lead at McKinsey's Healthcare practice who will provide an update on China's rapidly changing healthcare industry. Following this presentation, Greg Scott, Chair of AmCham's Healthcare Committee and Founder & Chairman of ChinaBio Group will share insights on investment in China's burgeoning life science industry and cross-border partnering opportunities.


9:30 Registration & Networking

9:45 Welcome Remarks

9:50 China Healthcare Industry Update – McKinsey

10:20 Investment Activity in China Life Science – ChinaBio

10:50 Audience Q&A

11:00 Session Ends/Networking


  • Greg Scott (Founder and Chairman of ChinaBio® Group)

    Greg Scott

    Founder and Chairman of ChinaBio® Group

    Greg founded ChinaBio® Group in 2007 to help life science companies and investors achieve success in China. ChinaBio® works with US, European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China. ChinaBio® has also organized over 30 conferences in China focused on investment and partnering, including the ChinaBio® Partnering Forum which draws nearly 1000 attendees from around the world to China each spring. Greg is also co-founder of two investment groups that have funded over 50 biotechnology and medical device companies in the US and China, and Executive Editor of ChinaBio® Today: a widely read newsletter covering the China life science industry. He also serves on the board of a medical device and cancer drug company, and formerly the BayHelix Group, a group of (mostly) Chinese life science executives. Headquartered in Shanghai, ChinaBio® has staff in San Diego, Palo Alto, and Basel, Switzerland. Greg lives and works in Shanghai and visits California a few times a year to enjoy the blue skies and sandy beaches.

    view more
  • Fangning Zhang (Co-Lead, Healthcare at McKinsey)

    Fangning Zhang

    Co-Lead, Healthcare at McKinsey

    Over the last 11 years Fangning has served leading Pharma and MedTech companies on business strategy, R&D, medical affairs, organization transformation etc.

    Example engagements include:
    – Formulated China innovation strategy for leading
    global healthcare company
    – Helped a leading pharma MNC to develop APAC
    medical affairs transformation roadmap
    – Drafted industry whitepaper on China pharma
    ▪ Fangning has developed broad network with China
    R&D and medical affairs leaders from MNC and local
    companies and hosts regular R&D & Medical Affairs
    roundtables among China pharmaco leaders
    ▪ Fangning is a regular speaker at leading China
    healthcare conferences, including China Trials (2015-
    17), DIA (2014, 2015, 2017), China Healthcare
    Investment Conference (2016), China Medical Affairs
    Conference (2016), China Medical Affairs Summit (2017)
    ▪ Publishes articles focusing on China healthcare
    innovation and supported industry-wide innovation
    initiatives, and spearheaded efforts to establish China
    Drug Innovation Index (CDII) since 2015

    view more


A prepayment is required when choosing 'Standard Price'.

Member Ticket
Member Price Free
Member Company Employee Ticket
Standard Price RMB 200
Door Price RMB 300
Non-Member Ticket
Standard Price RMB 500
Door Price RMB 600


AmCham Shanghai Conference Center

Suite 568, Shanghai Centre, 1376 Nanjing Road West
Shanghai, China

If you have any questions please contact

Contact Organizer

Show on map